DENTSPLY SIRONA Inc (NASDAQ: XRAY) has reported E.P.S. of $-2.46 for its third fiscal quarter (ending September 30) versus $-1.25 for the same period a year ago — an increase of 97%. E.P.S. were $-2.03 for the latest four quarters through September 30 versus $-1.01 for the same period a year ago — an increase of 101%.
Recent Price Action
DENTSPLY SIRONA Inc (NASDAQ: XRAY) stock suffered a major decline of -28.0% on 11/7/24. The shares closed at $17.26. Moreover, this decline was accompanied by exceptionally high trading volume at 1054% of normal. The stock has declined -26.3% during the last week and has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
XRAY’s future returns on capital are forecasted to be above the cost of capital. Accordingly, the company is expected to continue to be an important Value Builder.
DENTSPLY SIRONA has a current Value Trend Rating of D (Negative). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. DENTSPLY SIRONA has a neutral Appreciation Score of 49 but a poor Power Rating of 18, resulting in the Negative Value Trend Rating.
Rating Review
In light of this new information and highly negative price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment